MYD88 and cardiac hypertrophy: For instance, LM8-mediated MyD88 inhibition reportedly exerts beneficial effects for cardiac hypertrophy and fibrosis by reducing inflammatory cytokine expression as well as immune cell infiltration in obese mouse models (79).